Elamipretide
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 198 publications
Targeting Mitochondria in MASLD: Comparative Evaluation of MitoQ and SS-31 (Elamipretide) in Aged Female Mice under Nutritional Stress.
Journal: Physiological research
Published: September 08, 2026
Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic Brain Injury in Mice.
Journal: Neurochemical research
Published: July 08, 2026
AMCP Market Insights: Managed care considerations in Barth syndrome.
Journal: Journal of managed care & specialty pharmacy
Published: June 26, 2026
Elamipretide: a mitochondria-targeting drug for Barth syndrome.
Journal: Trends in pharmacological sciences
Published: May 07, 2026
Reactive oxygen species and antioxidant strategies in human sperm cryodamage.
Journal: Frontiers in medicine
Published: April 30, 2026
Clinical development in primary mitochondrial diseases at a translational inflection point: Lessons, mechanisms, and emerging therapeutic strategies.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 21, 2026
Is an emerging pharmacotherapeutic era for rare mitochondrial diseases here?
Journal: Cell metabolism
Published: April 18, 2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Journal: Sports medicine (Auckland, N.Z.)
Published: March 24, 2026
Mitochondrial Dysfunction at the Intersection of CKM Syndrome: Molecular Mechanisms and Path-to-Target Therapies.
Journal: International journal of molecular sciences
Published: March 24, 2026
Last Updated: 09/26/2026